AISAP

Point-of-Care Assisted Diagnosis

Startup

AISAP is a Ramat Gan-based startup in the Health Tech & Life Sciences sector, established in 2022. Point-of-Care Assisted Diagnosis. The company has raised a total of $13M across 2 funding rounds, currently at the Seed stage. AISAP was founded by Adiel Am-Shalom and Ehud Raanani. Key investors include Shoni Health Ventures, Harel Insurance & Finance. The company has 11-50 employees. Core technologies: Platforms & Interfaces, Software, Artificial Intelligence, Deep Learning, Simulation & Imaging, Ultrasound.

With $13M in total funding, AISAP is a Seed-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: Beta. The company holds 1 patent.

$13M
Raised
2
Rounds
2
Investors
5
Team
2022
Founded
1
Patents
Sector & Technology
Health Tech & Life SciencesDigital HealthcareDigital Medical DiagnosticsPlatforms & InterfacesSoftwareArtificial IntelligenceDeep LearningSimulation & ImagingUltrasound
At a Glance
Investors
Founders
In the News

13 articles covered by sources including www.businesswire.com, www.maariv.co.il, nocamels.com, www.calcalistech.com, chiportal.co.il.

www.businesswire.com · Mar 18, 2025
AISAP Named to Fast Company’s List of the World’s Most Innovative Companies of 2025
Read article ↗
Frequently Asked Questions
What does AISAP do?

AISAP supports clinicians using point-of-care ultrasound with real-time acquisition guidance, immediate interpretation, and multi-organ diagnoses, leading to exceptional clinical outcomes and health care efficiency. AISAP developed POCAD, an intuitive, easy-to-use, secure cloud-based platform that provides AI-powered ultrasound diagnosis anywhere and at any time, designed to empower clinicians and connect care teams to provide immediate, efficient, and fast treatment, right at the patient's bedside. POCAD is a deep-learning, secure, cloud-based platform that provides real-time analysis of images and data from any ultrasound device, assesses the patient’s condition, and predicts patient outcomes. AISAP’s CARDIO AI-powered Point-of-Care Ultrasound Diagnostic Software received FDA clearance.

How much funding has AISAP raised?

AISAP has raised $13M in total funding across 2 rounds. The company is currently at the Seed stage. Key investors include Shoni Health Ventures, Harel Insurance & Finance.

Who founded AISAP?

AISAP was founded in 2022 by Adiel Am-Shalom (Co-founder & CEO), Ehud Raanani (Co-Founder).

What sector is AISAP in?

AISAP operates in Health Tech & Life Sciences, Digital Healthcare, Digital Medical Diagnostics, with core technologies in Platforms & Interfaces, Software, Artificial Intelligence, Deep Learning, Simulation & Imaging, Ultrasound. Target customers: Healthcare & Life Sciences, Healthcare, Providers.

Where is AISAP located?

AISAP is based in Derech Sheba 2, Ramat Gan, Israel.

View Full Profile Classic View Website ↗